Our proprietary high-through put enabled platform evaluates morphology, genetic stability, and pluripotency markers which deliver a comprehensive score backed by validated criteria.
Despite advances in research, many scientists still face roadblocks that limit progress and increase the risk of failure. From unreliable animal models to inefficient workflows, the tools used today often fall short of what modern drug discovery demands.
iPSCore™ addresses longstanding bottlenecks in preclinical research by delivering human-relevant iPSC models through an integrated, scalable platform. Built for scientific rigor and operational efficiency, it enables researchers to move from donor tissue to assay-ready cells with greater confidence and control.
Accelerating Discoveries that Matter
iPSCore is a fully integrated, modular platform that simplifies iPSC-based research by connecting every critical step into a cohesive system, enabling faster, more reliable results.
Specimen Procurement | Cell Preparation & Isolation | Reprogramming | Genome Editing | Differentiation | Characterization | Manufacturing & Upscaling | Call-based Assays | Compound Screening
Whether you’re developing new medicines, advancing research, or supporting patient-focused studies, iPSCore provides the human-relevant models and tools you need.
Replace animal models with human-relevant iPSC assays that support target validation, IND-enabling studies, and high-throughput drug screening.
Access fully characterized, reproducible iPSC models—including gene-edited and disease-specific lines—for consistent results in mechanistic studies and disease modeling.
Develop ethically sourced, disease-specific cell models to explore rare conditions, support drug repurposing, and enable more meaningful translational outcomes.
Integrate validated iPSC workflows and assay-ready cells into client services, accelerating timelines and enhancing delivery across discovery and manufacturing.
Organizations across biotech, pharma, and academic research trust iPSCore to deliver the human-relevant models needed to advance disease-specific research and real-world discovery.
Projects and products delivers to
top 30 global BioPharma companies.
iPSC Lines and Rare Disease Projects,
with 50+ patient foundations supported.
of N=1 Collaborative Since 2023
With over a decade of experience in cellular biology and preclinical research, iXCells delivers human-relevant models that help researchers improve predictability and move new therapies forward.
Why Choose iXCells:
Core Procurement
Ethically sourced, IRB-approved human tissue or blood samples with full regulatory compliance.
Core Re-programming
Conversion of adult somatic cells into induced pluripotent stem cells (iPSCs) for patient-specific research models.
Core Genome Editing
High-efficiency CRISPR-based editing with customizable targeting for disease modeling and isogenic controls.
Core Differentiation
Directed differentiation into 27+ validated cell types—including motor neurons, cardiomyocytes, and hepatocytes.
Core Characterization
Rigorous validation for identity, purity, genetic stability, and functional performance.
Core Manufacturing
Scalable production under standardized protocols to support both small-batch and high-throughput research needs.
If you’re ready to discuss how iPSCore can support your research, complete the form below and a member of our team will reach out.
iPSCore is designed for scientific leaders, researchers, and organizations seeking scalable, human-relevant iPSC solutions to advance
drug discovery and translational research. Whether you’re driving research decisions, managing discovery programs, or advancing
patient-focused studies, iPSCore delivers:
iPSCore provides researchers with the tools and models needed to improve predictability and move studies forward with greater confidence.
